148 related articles for article (PubMed ID: 27061871)
1. Lung stereotactic ablative body radiotherapy: A large scale multi-institutional planning comparison for interpreting results of multi-institutional studies.
Giglioli FR; Strigari L; Ragona R; Borzì GR; Cagni E; Carbonini C; Clemente S; Consorti R; El Gawhary R; Esposito M; Falco MD; Fedele D; Fiandra C; Frassanito MC; Landoni V; Loi G; Lorenzini E; Malisan MR; Marino C; Menghi E; Nardiello B; Nigro R; Oliviero C; Pastore G; Quattrocchi M; Ruggieri R; Redaelli I; Reggiori G; Russo S; Villaggi E; Casati M; Mancosu P
Phys Med; 2016 Apr; 32(4):600-6. PubMed ID: 27061871
[TBL] [Abstract][Full Text] [Related]
2. Multicentre treatment planning inter-comparison in a national context: The liver stereotactic ablative radiotherapy case.
Esposito M; Maggi G; Marino C; Bottalico L; Cagni E; Carbonini C; Casale M; Clemente S; D'Alesio V; Fedele D; Giglioli FR; Landoni V; Martinotti A; Nigro R; Strigari L; Villaggi E; Mancosu P
Phys Med; 2016 Jan; 32(1):277-83. PubMed ID: 26498378
[TBL] [Abstract][Full Text] [Related]
3. The significance of PTV dose coverage on cancer control outcomes in early stage non-small cell lung cancer patients treated with highly ablative stereotactic body radiation therapy.
Shaverdian N; Tenn S; Veruttipong D; Wang J; Hegde J; Lee C; Cao M; Agazaryan N; Steinberg M; Kupelian P; Lee P
Br J Radiol; 2016; 89(1059):20150963. PubMed ID: 26764282
[TBL] [Abstract][Full Text] [Related]
4. Stereotactic ablative radiotherapy for ultra-central lung tumors: prioritize target coverage or organs at risk?
Murrell DH; Laba JM; Erickson A; Millman B; Palma DA; Louie AV
Radiat Oncol; 2018 Apr; 13(1):57. PubMed ID: 29606150
[TBL] [Abstract][Full Text] [Related]
5. Analysis of dose distribution and risk of pneumonitis in stereotactic body radiation therapy for centrally located lung tumors: a comparison of robotic radiosurgery, helical tomotherapy and volumetric modulated arc therapy.
Kannarunimit D; Descovich M; Garcia A; Chen J; Weinberg V; Mcguinness C; Pinnaduwage D; Murnane J; Gottschalk AR; Yom SS
Technol Cancer Res Treat; 2015 Feb; 14(1):49-60. PubMed ID: 24325136
[TBL] [Abstract][Full Text] [Related]
6. Radiobiological impact of dose calculation algorithms on biologically optimized IMRT lung stereotactic body radiation therapy plans.
Liang X; Penagaricano J; Zheng D; Morrill S; Zhang X; Corry P; Griffin RJ; Han EY; Hardee M; Ratanatharathom V
Radiat Oncol; 2016 Jan; 11():10. PubMed ID: 26800883
[TBL] [Abstract][Full Text] [Related]
7. Dosimetric impact of different CT datasets for stereotactic treatment planning using 3D conformal radiotherapy or volumetric modulated arc therapy.
Oechsner M; Odersky L; Berndt J; Combs SE; Wilkens JJ; Duma MN
Radiat Oncol; 2015 Dec; 10():249. PubMed ID: 26626865
[TBL] [Abstract][Full Text] [Related]
8. Dosimetric comparison of stereotactic body radiotherapy using 4D CT and multiphase CT images for treatment planning of lung cancer: evaluation of the impact on daily dose coverage.
Wang L; Hayes S; Paskalev K; Jin L; Buyyounouski MK; Ma CC; Feigenberg S
Radiother Oncol; 2009 Jun; 91(3):314-24. PubMed ID: 19111362
[TBL] [Abstract][Full Text] [Related]
9. Feasibility of using intravenous contrast-enhanced computed tomography (CT) scans in lung cancer treatment planning.
Xiao J; Zhang H; Gong Y; Fu Y; Tang B; Wang S; Jiang Q; Li P
Radiother Oncol; 2010 Jul; 96(1):73-7. PubMed ID: 20347496
[TBL] [Abstract][Full Text] [Related]
10. Dosimetric Consequences of 3D Versus 4D PET/CT for Target Delineation of Lung Stereotactic Radiotherapy.
Siva S; Chesson B; Callahan JW; Hardcastle N; Crawford L; Antippa P; Wright G; MacManus MP; Hicks RJ; Kron T; Ball DL
J Thorac Oncol; 2015 Jul; 10(7):1112-5. PubMed ID: 26134229
[TBL] [Abstract][Full Text] [Related]
11. Transition from a simple to a more advanced dose calculation algorithm for radiotherapy of non-small cell lung cancer (NSCLC): implications for clinical implementation in an individualized dose-escalation protocol.
Elmpt Wv; Ollers M; Velders M; Poels K; Mijnheer B; Ruysscher DD; Dekker A; Lambin P; Boersma L
Radiother Oncol; 2008 Sep; 88(3):326-34. PubMed ID: 18701177
[TBL] [Abstract][Full Text] [Related]
12. Dosimetric comparison of CT-guided iodine-125 seed stereotactic brachytherapy and stereotactic body radiation therapy in the treatment of NSCLC.
Li R; Zhang Y; Yuan Y; Lin Q; Dai J; Xu R; Hu X; Han M
PLoS One; 2017; 12(11):e0187390. PubMed ID: 29121047
[TBL] [Abstract][Full Text] [Related]
13. MLC tracking for lung SABR reduces planning target volumes and dose to organs at risk.
Caillet V; Keall PJ; Colvill E; Hardcastle N; O'Brien R; Szymura K; Booth JT
Radiother Oncol; 2017 Jul; 124(1):18-24. PubMed ID: 28655454
[TBL] [Abstract][Full Text] [Related]
14. Proton beam radiotherapy versus three-dimensional conformal stereotactic body radiotherapy in primary peripheral, early-stage non-small-cell lung carcinoma: a comparative dosimetric analysis.
Macdonald OK; Kruse JJ; Miller JM; Garces YI; Brown PD; Miller RC; Foote RL
Int J Radiat Oncol Biol Phys; 2009 Nov; 75(3):950-8. PubMed ID: 19801106
[TBL] [Abstract][Full Text] [Related]
15. Dosimetric comparison of helical tomotherapy and dynamic conformal arc therapy in stereotactic radiosurgery for vestibular schwannomas.
Lee TF; Chao PJ; Wang CY; Lan JH; Huang YJ; Hsu HC; Sung CC; Su TJ; Lian SL; Fang FM
Med Dosim; 2011; 36(1):62-70. PubMed ID: 20188537
[TBL] [Abstract][Full Text] [Related]
16. Incorporating heterogeneity correction and 4DCT in lung stereotactic body radiation therapy (SBRT): The effect on target coverage, organ-at-risk doses, and dose conformity.
Franks KN; Purdie TG; Dawson LA; Bezjak A; Jaffray DA; Bissonnette JP
Med Dosim; 2010; 35(2):101-7. PubMed ID: 19931021
[TBL] [Abstract][Full Text] [Related]
17. Dosimetric impact of breathing motion in lung stereotactic body radiotherapy treatment using intensity modulated radiotherapy and volumetric modulated arc therapy [corrected].
Rao M; Wu J; Cao D; Wong T; Mehta V; Shepard D; Ye J
Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):e251-6. PubMed ID: 22365622
[TBL] [Abstract][Full Text] [Related]
18. A modified formula for dose calculations of stereotactic ablative body radiotherapy for non-small cell lung cancer.
Cao Y; Zhu X; Zhang Y; Yu C; Liu Y; Sun Y; Dai Z; Guo X; Ju X; Zhang H
Med Dosim; 2018 Autumn; 43(3):207-213. PubMed ID: 28993019
[TBL] [Abstract][Full Text] [Related]
19. Feasibility of helical tomotherapy in stereotactic body radiation therapy for centrally located early stage non‒small-cell lung cancer or lung metastases.
Chi A; Jang SY; Welsh JS; Nguyen NP; Ong E; Gobar L; Komaki R
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):856-62. PubMed ID: 21255942
[TBL] [Abstract][Full Text] [Related]
20. Stereotactic ablative radiation therapy for subcentimeter lung tumors: clinical, dosimetric, and image guidance considerations.
Louie AV; Senan S; Dahele M; Slotman BJ; Verbakel WF
Int J Radiat Oncol Biol Phys; 2014 Nov; 90(4):843-9. PubMed ID: 25585783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
